CGEN Stock Summary and Trading Ideas (Compugen Ltd. - | NASDAQ:CGEN)

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.

Compugen Ltd. - trades on the NASDAQ stock market under the symbol CGEN.

As of March 13, 2026, CGEN stock price climbed to $2.24 with 294,407 million shares trading.

CGEN has a beta of 0.92, meaning it tends to be less sensitive to market movements. CGEN has a correlation of 0.07 to the broad based SPY ETF.

CGEN has a market cap of $209.47 million. This is considered a Small Cap stock.

Last quarter Compugen Ltd. - reported $67 million in Revenue and $.60 earnings per share. This beat revenue expectation by $52 million and exceeded earnings estimates by $.50.

In the last 3 years, CGEN traded as high as $3.03 and as low as $.53.

The top ETF exchange traded funds that CGEN belongs to (by Net Assets): SPDW, GWX.

CGEN has outperformed the market in the last year with a price return of +39.1% while the SPY ETF gained +21.4%. CGEN has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +46.4% and +23.8%, respectively, while the SPY returned -2.6% and -3.5%, respectively.

CGEN support price is $2.10 and resistance is $2.32 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CGEN shares will trade within this expected range on the day.